reports
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contri...
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity for nasal airway obstruction (NAO) patients seen in otolaryngology (ENT) practices, and the prevalence of anatomical causes. Results show that the prevalence of nasal valve collapse (NVC) is comparable to septal deviation and turbinate hypertrophy across all patients evaluated and in t...
Entellus Medical announces publication of the 1-year results of a rand...
Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon dilation with ongoing medical therapy for the treatment of persistent Eustachian tube dysfunction (ETD). Over 7.3 million people have symptoms of Eustachian tube dysfunction, including ear pain and pressure...
Three Directors sold 3,450,975 shares at 24.000USD.
Three Directors at Entellus Medical Inc sold 3,450,975 shares at 24.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
The Law Offices of Vincent Wong Notifies Investors of a Complaint on B...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce the commencement of a class action concerning the sale of Entellus Medical, Inc. (NASDAQ:ENTL) to Stryker Corporation (NYSE:SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The action concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stockholders by failing to adequately shop the Company before entering into this transaction and whether ...
The Law Offices of Vincent Wong Notifies Investors of an Investigation...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Entellus Medical, Inc. (NASDAQ:ENTL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stryker Corporation (NYSE: SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The investigation concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stoc...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ: ENTL) stock prior to December 7, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Entellus to Stryker Corporation (NYSE: SYK) for $24 in cash per share. To learn more about the action and your rights, go to: http://www.zlk.com/mna/entel...
ENTELLUS MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Annou...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Entellus Medical, Inc. (NASDAQ GM: ENTL)? Did you purchase any of your shares prior to December 7, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ GM: ENTL) ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ: ENTL) stock prior to December 7, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Entellus to Stryker Corporation (NYSE: SYK) for $24 in cash for share. To learn more about the action and your rights, go to: http://www.zlk.com/mna/regal...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.